[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Fecundis Lab SL\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":97},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,41,71],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100629736","safety-evaluation-of-the-hypersperm-sperm-preparation-procedure-for-in-vitro-fertilization-100629736",false,"NCT07478549","Safety Evaluation of the HyperSperm Sperm Preparation Procedure for In Vitro Fertilization","Prospective, Multicenter, Randomized Clinical Trial Evaluating the Safety of the HyperSperm Sperm Preparation Procedure.","Inclusion Criteria:\n\nGeneral\n\n* Couples undergoing in vitro fertilization (IVF) treatment.\n* Planned use of fresh sperm samples obtained by masturbation.\n\nFemale\n\n* Age between 20 and 42 years.\n* Antral follicle count ≥ 4.\n* Eligible for ovarian stimulation and embryo transfer.\n\nMale\n\n* Age between 20 and 45 years.\n* Fresh semen sample (not cryopreserved).\n* Pre-processing sperm concentration ≥ 5 × 10⁶ sperm\u002FmL.\n\nExclusion Criteria:\n\nGeneral\n\n* Active sexually transmitted infection (STI).\n* Use of donor sperm.\n* Medical conditions contraindicating pregnancy or the IVF procedure.\n\nFemale\n\n* Uterine anomalies associated with distortion of the uterine cavity.\n* Absence of one ovary or functional disorders preventing ovulation.\n* Diabetes mellitus or other metabolic disorders.\n* Recurrent pregnancy loss, defined as more than two clinical pregnancies without live birth.\n\nMale\n\n\\- Any medical condition affecting semen quality that, in the investigator's opinion, may interfere with study participation.","ALL","20 Years","45 Years",{"count":20,"type":21},202,"ESTIMATED","INTERVENTIONAL",[24],"NA","Prospective, multicenter, randomized clinical study evaluating the safety of a novel sperm preparation method for in vitro fertilization (IVF), compared to standard sperm preparation procedures.",[27],"Infertility","NOT_YET_RECRUITING","2026-06-23",{"date":31,"type":32},"2026-06-26","ACTUAL",{"date":34,"type":21},"2026-12",{"date":36,"type":21},"2028-05",{"name":38,"class":39},"Fecundis Lab SL","OTHER",2,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":16,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":61,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},"100628035","development-of-an-ai-platform-for-the-analysis-of-sperm-and-prediction-of-their-clinical-potential-100628035","NCT07456397","Development of an AI Platform for the Analysis of Sperm and Prediction of Their Clinical Potential","Development and Validation of an Artificial Intelligence Platform for the Analysis of Sperm Samples and Prediction of Their Clinical Potential","Spermy01","Male participants:\n\nInclusion Criteria:\n\n* Ability to provide a semen sample via masturbation\n* Semen sample intended for use in an IVF\u002FICSI cycle\n\nExclusion Criteria:\n\n* Current diagnosis of a sexually transmitted infection (STI)\n* Previous diagnosis of hepatitis A, B, C, D, or HIV\n* Prior participation in this study\n* Participation in a clinical trial involving an intervention within the last 3 months\n\nFemale participants:\n\nInclusion Criteria:\n\n* Urdengoing an IVF\u002FICSI cycle with partner or donor semen\n\nExclusion Criteria:\n\n* Prior participation in this study\n* Participation in a clinical trial involving an intervention within the last 3 months","18 Years","60 Years",{"count":52,"type":21},500,"OBSERVATIONAL","Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to develop an artificial intelligence platform for the analysis of sperm samples and prediction of their clinical potential, in 500 semen samples, in an in vitro study over 24 months.",[56,57,58,59,60],"Infertility (IVF Patients)","ICSI","IVF Outcomes","Male Infertility","Reproductive Issues","RECRUITING","2026-06-10",{"date":64,"type":32},"2026-06-12",{"date":66,"type":32},"2026-03-18",{"date":68,"type":21},"2028-02",{"name":38,"class":39},5,{"id":72,"slug":73,"hasResults":11,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":77,"eligibilityCriteria":78,"healthyVolunteers":79,"sex":80,"minAge":49,"maxAge":50,"enrollmentInfo":81,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":83,"conditions":84,"keywords":4,"overallStatus":61,"whyStopped":4,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},"100573142","efficacy-and-safety-of-a-new-sperm-capacitation-method-100573142","NCT06742437","Efficacy and Safety of a New Sperm Capacitation Method","Efficacy and Safety of a New Sperm Capacitation Method: a Prospective in Vitro Study on Semen Samples","HyperSperm01","Inclusion Criteria:\n\n* Ability to provide a semen sample via masturbation\n\nExclusion Criteria:\n\n* Current diagnosis of a sexually transmitted infection (STI)\n* Previous diagnosis of hepatitis A, B, C, D, or HIV\n* Prior participation in this study\n* Participation in a clinical trial involving an intervention within the last 3 months",true,"MALE",{"count":82,"type":21},300,"Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to evaluate the efficacy and safety of HyperSperm, a new sperm capacitation method, in 300 semen samples with various characteristics and abnormalities, in an in vitro study over 12 months.",[60,59,85,86,87],"Asthenozoospermia","Oligozoospermia","Teratozoospermia","2026-02-24",{"date":90,"type":32},"2026-02-27",{"date":92,"type":32},"2025-01-14",{"date":94,"type":21},"2026-06",{"name":38,"class":39},4,""]